Upload
trannhu
View
471
Download
53
Embed Size (px)
Citation preview
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
1
http://www.ijpfr.com
Platelet-Increasing Effects of Euphorbia hirta Linn.
(Euphorbiaceae) in Ethanol-Induced Thrombocytopenic Rat
Models
Jovencio G. Apostol1,2,3
, James Viktor A. Gan1, Ryan Justin B. Raynes
1, Anna Andrea S.
Sabado1, Andrea Q. Carigma
1, Librado A. Santiago
1,2,3, Mafel C. Ysrael
1,2,3
Department of Pharmacy, Faculty of Pharmacy, University of Santo Tomas, España, Manila, Philippines
1
UST- Research Center for Natural and Applied Sciences2
The Graduate School, University of Santo Tomas, España, Manila, Philippines3
The antithrombocytopenic effect of the solution of the lyophilized decoction of Euphorbia hirta was
investigated in Sprague-Dawley rats with subnormal platelet counts induced by ethanol. E. hirta decoction prepared by
boiling the fresh entire plant in distilled water for 15 minutes was lyophilized and the resulting solid was dissolved in
distilled water and used to determine total phenolics and to prepare stock solutions administered to thrombocytopenic
rats. The polyphenolic contents of the lyophilized decoction determined by Folin-Ciocalteu and Fast Blue BB assays
revealed the presence of more reducing phenolics than reducing non-phenolics. The antithrombocytopenic activity of E.
hirta was assessed by platelet count, bleeding time and clotting time determination in rats randomized into four groups.
Group A served as the treated group given 100mg/kg of E. hirta. Group B served as the positive control group given
intraperitoneal ethanol at 3g/kg body weight and Group C and D were identified as the vehicle and time control groups,
respectively. Results showed a significant increase in the platelet count and decrease in bleeding and clotting times in
the ethanol-induced thrombocytopenic rats given E. hirta for 14 days. Furthermore, comparisons of the histopathologic
examination results of all groups indicated decreased liver sinusoidal dilation in the E. hirta treated rats. Therefore, the
potential use of E. hirta as an antithrombocytopenic decoction is attributable to its effect on platelet distribution and
possibly to the platelet protective activity of its antioxidant polyphenolic constituents.
Keywords: Euphorbia hirta, thrombocytopenia, platelet, bleeding time, clotting time, polyphenolics
*Corresponding Author Email: [email protected]
INTRODUCTION
Thrombocytopenia (TCP) is a condition wherein there is an abnormally low platelet count in the body
(usually less than 150 x 109/L). This condition may result from intake of drugs such as alcohol,
heparin, chloramphenicol, and cancer chemotherapeutic drugs as well as from various diseases states
such as chronic liver disease and dengue hemorrhagic fever. Current treatment for this condition
involves the use of expensive recombinant thrombopoetin and interleukin-11 to stimulate platelet
production. Platelet transfusions have also been used, but with only limited efficacy in restoring
platelet count. [1] Evidently there is still a need for a more affordable and convenient supportive
treatment for these patients.[2] Euphorbia hirta is an annual herb that belongs to the family
Euphorbiaceae also known as Spurge family. The plant has a hairy stem that is much-branched from
the base. These ascending branches may be simple or forked with a reddish or purplish color where
broad leaves are attached. [3] This plant thrives in open wastelands, grasslands, pathways, and
roadsides. [4] Tannins, flavonoids, phenolic acids, saponins, and amino acids have been isolated from
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
2
leaves of the plant. [5] Other constituents isolated from the aerial parts of the plant include:
leucocyanidol, quercitol, camphol, quercetrin, dihydroellagitannins, and euphorbins. [6] Williams et
al. (1997) found that the stems and leaves of the E. hirta contained angiotensin converting enzyme
inhibitors using enzyme linked immunosorbent assay. [7] The fresh leaves of E. hirta are traditionally
used in the Philippines as a cure for dengue fever. Other folkloric uses include: as an anti-asthmatic
[4], antimicrobial [8-10], diuretic [11], and anti-inflammatory [12]. The plant has also been found to
exhibit a sedative-anxiolytic activity [13] and gastrointestinal motility stimulating properties (5).
Previous studies have reported the antioxidant activity of E. hirta [14,15]. The lyophilized aqueous
extract was found to be non-toxic when administered either IP or PO to mice at doses up to 100mg/Kg
[13]. The decoction of E. hirta is reported to increase platelet count when administered per orally,
however, substantial evidence about its effects on platelets and other blood components are limited.
[4] Since the plant’s reputation as a traditional treatment is based largely on anecdotal accounts of its
efficacy, health officials are cautious about recommending its use until a more concrete understanding
of the plant’s pharmacologic action is obtained. It is possible that the anti-thrombocytopenic effect is
due to inhibition of platelet oxidation because of the polyphenolic compounds in the crude extract [14,
15]
The chronic use of ethanol has been known to cause thrombocytopenia by altering platelet distribution
which would subsequently lead to the platelets being sequestered into the spleen. [16] As one of the
most popular substances used worldwide with a variety of commercial and industrial applications,
ethanol was used in this study for the induction of thrombocytopenia.
This study was conducted to determine the validity of the anti-thrombocytopenic effect of E. hirta in
animal models with subnormal platelet counts due to ethanol. The platelet count, bleeding time, and
clotting time was determined to assess this effect of the plant. Histopathological analysis of the liver
and spleen was conducted to obtain further evidence of the mechanism of E. hirta in
thrombocytopenia. The total phenolics of the plant were confirmed using the Folin-Ciocalteu Method
and Fast Blue BB Assay. This research is directed at providing evidence to substantiate the use of E.
hirta as a possible form of treatment for drug and disease-induced thrombocytopenia.
MATERIALS AND METHODS
Reagents and Equipment:
Reagent grade Folin-Ciocalteau reagent, sodium carbonate, and 95% ethanol was purchased from
Belman Laboratories (Philippines). Fast Blue BB reagent was from Ms. Marjorie B. Medina of the US
Department of Agriculture. Thermo-Heto Powder Dry LL 300 Freeze Dryer by Thermo Fisher
Scientific, (Pittsburgh, PA USA) was used. All substances used were reagent grade. Micros Counter
(Johnson & Johnson USA) was used to determine the platelet count. Genesys 10 UV/Vis
Spectrophotometer from Excellent Technology Co. (China) was used to take the absorbances.
Plant collection and Authentication:
Euphorbia hirta was collected from its natural habitat in San Luis, Pampanga, Philippines. A sample
specimen was declared authentic through a certificate (Control No. 240, OR No. 7079360) issued by
Dr. Wilfredo F.Vendivil of the National Museum of Philippines.
Preparation of Euphorbia hirta decoction:
A decoction was made by boiling 100 grams of fresh whole plant, previously washed of adhering soil
and debris, in 500 mL of water for 15 minutes at 100oC. The decoction was vacuum filtered, stored in
glass vials, and frozen for subsequent lyophilization. The percent yield was computed with the
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
3
lyophilized extract. The lyophilized extract was then refrigerated for future use for the Phenolic
Content assay and treatment for the thrombocytopenic rats.
Determination of Total Phenolic Content:
Folin-Ciocalteu Method
The preparation method for this test followed a micronized procedure. [17] Stock solutions of 0.7 M
sodium carbonate and 10 gallic acid standard solutions of decreasing concentrations were prepared
ranging from 0.5 mg/mL decreasing to 9.7 x 10-1
µg/mL Twenty milligrams of lyophilized extract was
initially used in the serial dilution. Concentrations of the five stock solutions of extract were obtained
ranging from 2 mg/mL decreasing to 0.125 mg/mL.
50 microliters of GA standard or sample was transferred into borosilicate tubes which was followed
by the addition of 430 microliters of distilled water and 20 microliters of Folin-Ciocalteu reagent. The
resulting mixture was thoroughly mixed and saturated Na2CO3 (50 microliters) were added. An
additional 450 microliters of distilled water was added and was allowed to react for 1 hour. The
optical density was measured at 765 nm. This procedure was done in five replications.
The amount of phenolic compounds equivalents to gallic acid in E. hirta was determined by
comparing the absorbance of the sample to the gallic acid standard curve.
Fast Blue BB Method
Using a 100 ppm (µg/mL) gallic acid concentration, the spectrophotometric scan (200-800 nm) of
Fast Blue BB and gallic acid interaction was determined. Gallic acid (0.1 mL of 100 ppm) was
transferred to borosilicate tubes, followed by the addition of 0.1 mL Fast Blue BB (0.05 or 0.025%),
and mixed for 1 min. Saturated Na2CO3 (0.1 mL) was added, and the absorbance was scanned at 60
minutes reaction time. Blanks were also used to correct for non-phenolic constituents that may have
an optical density near the specified wavelength. This procedure was done in five replications.
Test Animals:
Animal protocol was done in accordance with Institutional Animal Care and Use Committee
guidelines. Approval of animal protocol was secured from the Philippine Department of Agriculture
Bureau of Animal Industry (Reference No AR-2011-022) before animal procurement.
Male Sprague-Dawley rats, weighing 180-200 grams were purchased from the University of the
Philippines Manila Department of Pharmacology. The animals were housed in the University of Santo
Tomas Research Center for the Natural and Applied Sciences Animal House for 7 days for
acclimation. The animals were maintained under the standard conditions of relative humidity
(55±5%), temperature (22-250C) and lighting sequence of 12 h light, 12 h dark phases. All animals
were fed standard rat pellet diet and given free access to water. Food and water were both replenished
daily. Experimental animals were handled in accordance with protocols approved by the University of
Santo Tomas Institutional Animal Care and Use Committee (UST-IACUC). The test animals were
divided into 4 groups (A, B, C, and D) with 6 animals in each group. Group A served as the test group
which was given the E. hirta decoction after thrombocytopenia induction, Group B was given ethanol
only and served as the positive control, Group C was the vehicle control which was given an equal
volume of water during the E. hirta administration, Lastly, Group D served as the time control which
did not receive any treatment during the course of the experiment.
Platelet Count Determination:
Blood was collected via the tail-tipping method. The tip of the tail was cleaned with alcohol and 2
mm was cut with sharp scissors. One drop of blood was allowed to flow and the second drop of blood
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
4
was placed on a glass slide for the clotting time determination. Next, 0.5 mL of blood was collected in
EDTA tubes for platelet count on Micros Counter. A total of 4 blood collections were performed on
all test animals: before induction of thrombocytopenia (day 0), 7 days after induction of
thrombocytopenia (day 7), 7 days after E. hirta administration (day 14), and 14 days after E. hirta
administration (day 21).
Bleeding Time Determination:
Bleeding time was determined using Duke’s method with some modifications. The exposed tail tip
from the blood extraction was cleaned with distilled water and sterile gauze. The bleeding tip was
blotted on a #9 Whatman filter paper until no more blood was seen on the filter paper. The time from
first application to the disappearance of blood was recorded. This procedure was repeated during
every blood collection.
Clotting Time Determination:
The blood drop collected on the glass slide was rubbed using a lancet until fibrin threads were seen.
The time from first contact with lancet and the formation of threads was recorded. This procedure was
repeated during every blood collection.
Induction of Thrombocytopenia:
Groups A and B were used in the induction of thrombocytopenia. These groups were administered
with ethanol 3 g/ kg body weight intraperitoneally for 7 days. [16]
Euphorbia hirta Treatment :
Group A, after induction of thrombocytopenia by ethanol, was administered Euphorbia hirta
decoction at a dose of 100 mg/kg body weight by oral gavage. The decoction was given for fourteen
days and blood collections were done on the 7th
and 14th
days of treatment.
Histopathological Examination:
The test animals were killed by cervical dislocation after all relevant procedures. The liver and spleen
were isolated and sent to High Precision Diagnostics (Philippines) for slide preparation. Comparisons
between group A (Ethanol + E. hirta decoction), group B (Ethanol alone), and the time control (no
treatment) group were made.
All readings were done by a certified histopathologist and subject to his observations. The liver was
inspected for sinusoidal dilation, for dilation of the central vein, and for cloudy swelling. The findings
for sinusoidal dilation were categorized as 1+ (10-20%), 2+ (30-50%), or 3+ (>50%). The remaining
criteria were categorized as positive or negative.
Presence of sinusoidal dilation, hyperplasia with white pulp, and congestion with red pulp was
observed in the spleen. Sinusoidal dilation of the spleen was categorized similar to that of the liver.
Spleen hyperplasia was observed as positive or negative, and congestion of the spleen was ranked as
negative, 1+ (mild), 2+ (moderate), or 3+ (marked).
Statistical Treatment of Data:
All statistical analyses were performed at a 0.05 level of significance using SPSS 17.A dependent t-
test was performed to verify a significant decrease of platelet count, increase of bleeding and clotting
time after induction with ethanol. One-Way Analysis of Variance (ANOVA), with Tukey’s HSD test
as a post-hoc procedure, was used to determine if there exist significant differences in the E. hirta
treated, time, and vehicle control groups during the course of the treatment phase. A Kruskal-Wallis
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
5
analysis of variance was used to compare the sinusoidal dilation of the liver and spleen and splenic
congestion while a generalized Fisher’s exact test (SAS 9.0) was used for the rest of the
histopathological analysis of the E. hirta treated, time, and vehicle control groups.
RESULTS AND DISCUSSION
Plant Decoction, Lyophilized Extract and Percentage Yield:
The choice of solvent and condition of plant material was made to emulate the traditional way of
preparing E. hirta by the native Filipinos. A decoction, made from fresh E. hirta plant, appeared as a
brown solution prior to vacuum filtration. After lyophilization, the end product appeared as a brown
powder. It was found that lyophilization preserves the activity of E. hirta. [18] The net yield was
computed to be 48% from the fresh plant material.
Abubakar (2009) stated that water is the best extracting solvent for E. hirta; however, the percentage
yield obtained in this study is much higher compared to his preparation which resulted in a net yield
of only 3.9% (3). The age of the plant and the condition of the plant material upon extraction is the
most likely cause of the big difference in the net yield as his study utilized dried plant material while
this study extracted from fresh E. hirta plant. It is to be noted that fresh E. hirta will yield more active
constituents than the dried plant. [18]
Total Phenolic Content:
A gallic acid standard curve was obtained by plotting concentration versus absorbance at 765 nm. The
curve yielded an R2 value of 0.9996 in Folin-Ciocalteu and 0.9987 in Fast Blue BB.
The milligram gallic acid equivalent (GAE) per 100 mg sample derived from the regression line is
1.92 ±0.06 expressed as 3.00% relative standard deviation from the Folin-Ciocalteu method and 2.54
± 0.09 expressed as 3.00% relative standard deviation from the Fast Blue BB method.
The results from the Folin-Ciocalteu assay indicate the reducing property of substances (i. e.
antioxidant potential). This method is based on the reduction of tungsten and molybdenum oxides
yielding a color change in E. hirta from yellow to blue. This blue color has a maximal absorption at
765 nm. The intensity of absorption is proportional to the concentration of polyphenolic compounds
(Table 1). The results from Fast Blue BB method is based on interactions of phenolics with Fast Blue
BB diazonium salt in alkali pH, forming azo complexes, with the absorbance measured at 200-800 nm
(Table 2). In most cases, Fast Blue BB would yield higher ratios of total phenolics as compared to the
Folin-Ciocalteau assay due to direct action with phenolics. [19, 20] Polyphenols have demonstrated
excellent antioxidant properties. [18]
TABLE 1 Total phenolics from E. hirta by Folin-Ciocalteu
Stock GAE SD GAE (mg) SD
Mg/mL Stock Stock 100mg Ex 100mg Ex % RSD
E. hirta 21.0 40.31 1.21 1.92 0.06 3.00
TABLE 2 Total phenolics from E. hirta by Fast Blue BB
Stock GAE (mg) SD GAE (mg) SD
Mg/mL Stock Stock 100mg Ex 100mg Ex % RSD
E. hirta 21.0 53.34 1.82 2.54 0.09 3.42 SD: Standard Deviation Ex: Extract
Olas et al. (2004) noted that induced platelet oxidation by peroxynitrite, a highly reactive oxidizing
species, causes the inhibition of platelet activation, reducing the different steps of platelet activation:
adhesion of platelets to collagen and fibrinogen, platelet aggregation and secretory process. It was
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
6
found that peroxynitrite reacts with the thiol groups of the blood proteins. Furthermore, the prevention
of further oxidation was countered by the radical scavenging abilities of antioxidants, namely tea
polyphenolics and resveratrol. [21] In our study, the ratio (1.32) of polyphenolics obtained by Fast
Blue BB to Folin-Ciocalteu indicates the presence of more reducing phenolics than reducing non-
phenolics in E. hirta. [19] The effect of E. hirta is analogous to the application of antioxidants to
counter platelet oxidation and platelet dysfunction. By reducing platelet oxidation, platelet function
and lifespan are maintained, thus improving platelet count, bleeding and clotting times.
Effect of Euphorbia hirta on Platelet Count
Platelet counts were significantly decreased (p<0.05) after induction with ethanol. This decrease in
platelet count corresponds to the altered platelet distribution by ethanol which is responsible for the
development of thrombocytopenia. [22]
After 7 days of induction, there was a significant decrease in the platelet count in the rats given
ethanol. [840.00 ± 58.45 to 722.83 ± 43.65; t(df = 5)=4.082, p=0.010] compared to the baseline. This
13.3 ± 2.8% decrease in the platelet count was most likely caused by ethanol causing portal
hypertension and hypersplenism which resulted in thrombocytopenia. [23] These two factors cause
sequestration and accumulation of platelets in the spleen, decreasing the number of platelets available
in the periphery. Additionally, liver damage by ethanol can decrease production of thrombopoeitin
which decreases platelet production. [24, 25] E. hirta administration significantly increased platelet
count after 7 days [722.83 ± 43.65 to 982.83 ± 19.34; t(df=5)=5.128, p=0.004] by 38.9 ± 9.6%
compared to induction values. Continued administration until the 14th
day resulted in a significant
increase in platelets [722.83 ± 43.65 to 933.17 ± 95.38; t(df=5)=2.248, p=0.074] by 30.3 ± 13.9%
relative to induction values. Comparison between 7th
and 14th
day treatment values showed no
significant difference in the platelet count (Figure 1). The mean platelet count values of ethanol-
induced TCP rats did not significantly decrease from seventh day to 14 days after E. hirta treatment
indicating that the platelet count increase is sustained. This effect is attributable to improved platelet
redistribution from the spleen.
FIGURE 1 Platelet count comparison between ethanol induced rats and vehicle and time controls indicating significant
improvement (722.83 to 982.83109/L) after E. hirta administration(100mg/Kg BW/day) after 14 days. Results are
expressed as mean ± SEM.
Baseline 7 day Induction Treatment with E. hirta Treatment with E. hirta with Ethanol after 7 days after 14 days
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
7
Effect of Euphorbia hirta on Bleeding and Clotting Time
Bleeding time is a parameter to assess hemostatic function. Hemostatic function is usually assessed
through the Duke’s method reflecting hemorrhagic potential. Upon induction with the ethanol,
bleeding times significantly increased [2.70 ± 0.37 to 6.22 ± 0.66; t(df = 5)=3.973, p=0.011] by 174.0
± 73%. The increase in bleeding time predisposes to prolonged hemorrhage and consequently
excessive blood loss. This directly correlates with the decrease in the number of platelets in
circulation, previously discussed. Upon administration of E. hirta, bleeding times significantly
improved by 49.5 ± 9.7% from induction values after 7 days [6.22 ± 0.66 to 2.97 ± 0.42;
t(df=5)=4.070, p=0.010], and improved by 59.38 ± 6.44% compared to induction values after 14 days
[6.22 ± 0.66 to 2.46 ± 0.37; t(df=5)=5.815, p=0.002]. The mean bleeding time of ethanol-induced
TCP rats did not differ from seventh day to 14 days (Figure 2). Improvement of bleeding time is
critical in hemorrhagic disorders such as DHF to reduce the number and severity of bleeding episodes.
FIGURE 2 Bleeding time comparison between ethanol-induced thrombocytopenic groups and vehicle and time
controls. Drug induced rats exhibited increased bleeding time which was decreased by E. hirta administration
(100mg/Kg BW/day) after 14 days (6.22-.2.46 minutes). Results are expressed as mean ± SEM.
Clotting time measures the degree of activation of the coagulation pathways. Unlike bleeding time
which measures hemostasis, clotting time assesses coagulation and the functionality of the clotting
factors. Clotting times significantly increased [0.83 ± 0.12 to 1.25 ± 0.15; t(df = 5)=6.041, p=0.002]
by 53.2 ± 10.5% after induction. These increases reflect the alteration of coagulation process and
clotting factor function by ethanol. Not only was the inducing agent able to affect platelet count, it
was also able to disrupt the coagulation process. These effects were reversed by 7 day administration
of Euphorbia hirta [1.25 ± 0.15 to 0.66 ± 0.15; t(df=5)=3.811, p=0.012] with improvements of 46.6 ±
11.3% from induction values, and on the 14th
day [1.25 ± 0.15 to 0.57 ± 0.10; t(df=5)=3.849,
p=0.012] of 50.8 ± 10.6%. The mean clotting time of ethanol-induced TCP rats did not significantly
decrease from seventh day to 14 days after E. hirta treatment (Figure 3).
Baseline 7 day Induction Treatment with E. hirta Treatment with E. hirta with Ethanol after 7 days after 14 days
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
8
FIGURE 3 Clotting time comparison between ethanol-induced thrombocytopenic groups and vehicle and time controls.
Drug induced rats exhibited increased clotting time that was decreased by E. hirta administration (100mg/Kg BW/day)
after 14 days (1.25-0.57 minutes). Results are expressed as mean ± SEM.
Histopathological Examination
Tissue examination of the liver and spleen provided further evidence of thrombocytopenia as induced
by ethanol and the curative effects of the E. hirta decoction. Liver damage, which can result from
chronic intake of ethanol, leads to an increase in the blood pressure of the portal veins which will
impede the flow of blood out of the spleen. This leads to the platelets being sequestered in the spleen.
[26] The dilation of the sinusoids of these organs are often the result of poor venous outflow. [27]
The dilated sinusoids of the liver of the ethanol + E. hirta decoction group, the ethanol group, and the
control group were significantly different [p=0.031]. The ethanol + E.hirta decoction group differed
significantly from the ethanol only group [p = 0.012], but was similar to the control group [p = 0.317].
The ethanol only group was marked with dilations that are 2+ and 3+ while the ethanol + E. hirta
group and the control group only had the presence of 1+ and 2+ dilations (Table 3). Figures 4 and 5
shows the sinusoidal dilation of the ethanol + E. hirta group and the ethanol only group. Dilation of
the central vein of the liver and cloudy swelling of the liver were found to be similar for all three
groups [p=0.250].
TABLE 3 Degree of sinusoidal dilation of the liver in the different animal groups.
Groups Designation 1+ 2+ 3+ Median [IQR] p-value
1: Ethanol +
Euphorbia
Test group
(Group A)
25% 16.67% 0% 1+ [1+ to 2+]
0.031
2: Ethanol positive Postive Control
(Group B)
0% 16.67% 33.33% 3+ [2+ to 3+]
3: Control Time &
Vehicle
Control
(Group C&D)
0% 8.33% 0% 2+ [2+ to 2+]
Pairwise comparison: (1=3)<(2)
Baseline 7 day Induction Treatment with E. hirta Treatment with E. hirta with Ethanol after 7 days after 14 days
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
9
FIGURE 4 Representative image of the liver of Sprague-Dawley rats (n=6; p-value=0.031) given ethanol only
showing dilated sinusoids (2+, 3+) and partial tissue necrosis.
FIGURE 5 Representative image of the dilated sinusoids (1+, 2+) of the liver of Sprague-Dawley rats
(n=6; p-value=0.031) given ethanol + E. hirta decoction
FIGURE 6 Representative image of the liver of the control group showing minimal sinusoidal dilation.
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
10
Evidence of sinusoidal dilation was also found in the spleens of the test animals. White pulp is where
the T-cells and B-cells are located which provides an immune response to blood borne antigens. The
red pulp serves to filter blood constituents and to store red-blood cells and platelets [28]. Spleen
hyperplasia and congestions are the results of circulatory diseases which in this case is due to liver
damage. This malfunction of the normal processes of the organ leads to thrombocytopenia because of
the sequestration of platelets into the spleen. No notable difference was seen in the spleen sinusoidal
dilation [p=0.444], white pulp hyperplasia [p=0.748], and red pulp congestion [p=0.162] of the three
animal groups. This was most likely due to the short duration (1 week) of induction of
thrombocytopenia may have caused liver damage but was insufficient to cause any significant
changes to the spleen.
CONCLUSION
In conclusion, administration of 100mg/kg of the lyophilized decoction of E. hirta increased platelet
count in ethanol-induced thrombocytopenia after 7 days of administration. Continued administration
of the plant decoction resulted in the maintenance of this anti-thrombocytopenic effect. Improvement
of previously impaired hemostatic function is most likely due to the correction of altered platelet
distribution and sequestration caused by ethanol. Histopathological results, specifically liver
sinusoidal dilation, further corroborate these findings. Based on the results of the polyphenolic assays,
E. hirta contains more reducing polyphenols than non-polyphenolic compounds. Although this study
has established the hematologic effects of E. hirta relative to thrombocytopenia, further studies are
required to identify the polyphenols and relate their specific activity on platelets and platelet function.
FIGURE 7: Comparison between spleen tissue in Ethanol only group (top), in ethanol + E. hirta
decoction (middle), and control group (bottom). No notable differences were observed.
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
11
ACKNOWLEDGEMENT
We are grateful for the generous support of the Philippine Department of Science and Technology-
Science Education Institute (DOST-SEI) and the invaluable suggestions of Dr. Rowen Yolo MD.
REFERENCES
1. Peeters K, Stassen JM, Collen D, Geet CV, Freeson K. Emerging treatments for
thrombocytopenia: Increasing platelet production. Drug Discovery Today 2008; 13:798-806.
2. http://www.ifrc.org/docs/appeals/rpts11/PHep14011102.pdf (accessed November 2, 2011).
3. Abubakar EM. Antibacterial activity of crude extracts of Euphorbia hirta against some
bacteria sssociated with enteric infections. Journal of Medicinal Plant Research
2009;3(7):498-505.
4. Quisumbing E. Medicinal Plants of the Philippines. Manila: Dept. of Agriculture & Natural
Resources; 1951.
5. Hore SK, Ahuja V, Mehta G, Kumar P, Pandey SK, Ahmad AH. Effect of Aqueous
Euphorbia hirta Leaf Extract on gastrointestinal motility. Fitoterapia 2006; 77. 35-38.
6. Sudakar M, Rao C, Rao P, Raju D, Venkateswarlu Y. Antimicrobial activity of Caesalpinia
pulcherrima, Euphorbia hirta and Asystasia gangeticum. Fitoterapia 2006; 77: 378-380
7. Barbosa JM, Martins V, Rabelo L et al. Natural products inhibitors of the angiotensin
converting enzyme (ACE). A review between 1980-2000. Re.bras.farmacogn 2006; 16(3)
8. Kumar OA, Naidu LM, Rao KG. Antibacterial Evaluation of Snake Weed (Euphorbia hirta
L.) Journal of Phytology 2010; 2:2075-6240.
9. Ogbulie JN, Ogueke CC, Okoli IC, Anyanwu BN. Antibacterial Activities and Toxicological
Potentials of Crude Ethanolic Extracts of Euphorbia hirta. African Journal of Biotechnology
2007; 6:1544-1548.
10. Vijaya K, Anathan S, Nalini R. Antibacterial Effect of theaflavin, polyphenon 60
(Camilliasinensis) and Euphorbia hirta on Shigella spp. – a cell culture study. Journal of
Ethnopharmacology 1995; 49:115-118.
11. Johnson PB, Abdurahman EM, Tiam EA, Abdu-Aguy I, Hussaini IM. Euphorbia hirta leaf
extracts increase urine output and electrolytes in rats. Journal of Ethnopharmacology 1995;
65:63-69.
12. Youssouf MS, Kaiser P, Tahir M et al. Anti-anaphylactic Effect of Euphorbia hirta.
Fitoterapia 2007; 78:535-539.
13. Lanhers MC, Fleurentin J, Cabalion P, Rolland A, Dorfman P, Misslin R, Pelt JM. Behavioral
Effects of Euphorbia hirta L: Sedative and Anxiolytic Properties. Journal of
Ethnopharmacology 1990; 29: 189-198.
14. Basma AA, Zakaria Z, Latha LY, Sasidharan S. Antioxidant activity and phytochemical
screening of the methanol extracts of Euphorbia hirta L. Asian Pacific Journal of Tropical
2011;4:386-390. 15. Sharma NK, Prasad R. Oxidative injury to protein and their protection by phenolic acid
antioxidants from Euphorbia hirta leaves. Journal of Biotechnology (2008); 136:720
16. Littleton J, Fenn CG, Umney ND, Yazdanbakhsh M. Effect of Ethanol administration on
platelet function in the rat. Alcoholism: Clinical and Experimental Research (2008); 6(4):
512-519.
17. Waterhouse AL. Determination of Total Phenolics. In Wrolstad R, Acree TE, Decker EA,
Penner MH, Reid DS, Schwartz SJ et al. eds. Current Protocols in Food Analytical
Chemistry (Supplement 6). John Wiley & Sons, Inc; 2002: 463-482.
18. Duez P, Livaditis A, Guissoi PI, Sawadogo M, Hanocq M. Use of an Amoeba proteus model
for in vitro cytotoxicity in phytochemical research. Application to Euphorbia hirta extract.
Journal of Ethnopharmacology 1991; 34:235-246.
IJPFR, Jan-Mar 2012; 2(2):1-11 Original research article ISSN 2249 – 1112
Apostol et al © 2012 International Journal of Pharmaceutical Frontier Research
12
19. Medina M. Determination of the total phenolics in juices and superfruits by a novel chemical
method. Journal of Functional Food 2011;3: 79-87.
20. Lester G, Lewers K, Medina M, Saftner R. Comparative analysis of strawberry total
phenolics via Fast Blue BB vs. Folin-Ciocalteu: Assay interference by ascorbic acid. Journal
of Food Composition and Analysis 2012; 27:102-107.
21. Olas B, Nowak P, Kolozijczyk J, Wachowicz B. The Effects of Antioxidants on
Peroxynitrite-induced Changes in Platelet Proteins. Thrombosis Research 2004; 113:399-
406.
22. Rodak BF, Fritsma G A, Doig K. Hematology: Clinical Principles and Applications.
Singapore: Elsevier; 2009.
23. Afdhal N, McHutchison J, Brown J et al. Thrombocytopenia Associated with Chronic Liver
Disease. Journal of Hepatology 2008; 48:1000-1007.
24. Salem RO, Laposata M. Effects of Alcohol on Hemostasis. American Journal of Clinical
Pathology 2005; 123:96-105.
25. Ballard HS. The Hematological Complications of Alcoholism. Alcohol Health & Research
World 1997; 21(1):42-52.
26. Brunicardi FC, Andersen DK, Biliar TR et al. Schwartz’s Principles of Surgery. McGraw-
Hill Professional; 2009.
27. Kakar S, Kamath P, Burgart L. Sinusoidal Dilatation and Congestion in Liver Biopsy.
Archives of Pathological and Laboratory Medicine 2004; 128:901-904.
28. Vanhoenacker FM, Beeck B, De Schepper AM, Salgado R., Scnoeckx A, Parizel PM.
Vascular Diseases of the Spleen. Seminars in Ultrasound, CT, and MRI 2007; 28(1): 35-51.